TrialCardiovascular drugs and therapy2026

Low-Dose Rivaroxaban vs. Aspirin in Addition to Clopidogrel After Percutaneous Coronary Intervention in Coronary Atherosclerotic Heart Disease Patients with Gastrointestinal Disease.

Yue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.